Esma Saada Selected Research

Esma Saada Research Topics

7	Squamous Cell Carcinoma of Head and Neck 07/2021 - 09/2016
6	Neoplasms (Cancer) 07/2022 - 03/2019
5	Sarcoma (Soft Tissue Sarcoma) 09/2021 - 07/2015
4	Hypopharyngeal Neoplasms 02/2023 - 09/2016
4	Deglutition Disorders (Dysphagia) 02/2023 - 01/2015
3	Head and Neck Neoplasms (Head and Neck Cancer) 07/2021 - 11/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 02/2017
2	Aggressive Fibromatosis (Desmoid) 12/2020 - 01/2019
2	Disease Progression 01/2020 - 01/2019
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2020 - 09/2009
2	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2019
2	Neutropenia 01/2020 - 01/2019
2	Hypertension (High Blood Pressure) 01/2019 - 01/2019
1	Carcinoma (Carcinomatosis) 02/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Polyploidy 01/2021
1	Pneumothorax 01/2020
1	Fatigue 01/2019
1	Chest Pain (Chest Pains) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Body Weight (Weight, Body) 09/2016
1	Weight Loss (Weight Reduction) 09/2016
1	Hemangioendothelioma 01/2014
1	Hemangiosarcoma (Angiosarcoma) 01/2013

4	Cisplatin (Platino)FDA LinkGeneric 02/2023 - 09/2016
3	Fluorouracil (Carac)FDA LinkGeneric 02/2023 - 09/2016
3	Docetaxel (Taxotere)FDA Link 02/2023 - 09/2016
2	Dioctyl Sulfosuccinic Acid (DOSS)IBA 07/2022 - 01/2015
2	pazopanib FDA Link 09/2021 - 01/2019
2	Phosphotransferases (Kinase)IBA 09/2021 - 01/2021
2	Cetuximab (Erbitux)FDA Link 12/2020 - 02/2017
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 07/2021
1	onvansertibIBA 01/2021
1	Polo-Like Kinase 1IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	CateninsIBA 12/2020
1	avelumabIBA 12/2020
1	cabozantinibIBA 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2019
1	regorafenibIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	tetraethylpyrazine (TEP)IBA 09/2016
1	Sunitinib (Sutent)FDA Link 01/2014
1	ParaffinIBA 01/2013

6	Therapeutics 02/2023 - 09/2016
4	Drug Therapy (Chemotherapy) 12/2020 - 09/2009
3	Enteral Nutrition (Feeding, Tube) 02/2023 - 09/2016
3	Induction Chemotherapy 02/2023 - 09/2016
3	Aftercare (After-Treatment) 02/2023 - 01/2019
3	Radiotherapy 01/2021 - 02/2017
2	Laryngectomy 02/2023 - 10/2016
1	Combined Modality Therapy 07/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2019
1	Free Tissue Flaps 01/2017
1	Perioperative Period 11/2016